STEM-CORE Stem Cell Therapy Development for Corneal Epithelium Regeneration
- Coordinator
- Stichting Radboud Universiteit, Netherlands
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €4.1m
- Total cost
- —
- Partners
- 18 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226474
What the project is doing
In the project's own words, from its summary on CORDIS.
Corneal disease ranks as the fourth major cause of blindness, imposing a significant medical, social, and economic burden. Effective therapeutic options for corneal disease are unfortunately limited. The development of regenerative treatment has proven more complex than anticipated. Bridging the gap between cutting-edge scientific and technological advancements and their clinical applications in ocular regenerative medicine requires equipping the next generation of (medical) researchers with comprehensive training to drive innovation and facilitate clinical translation.
STEM-CORE aims to reshape European doctorate education, through ‘training through innovative research’, nurturing future leaders in ocular regenerative medicine and beyond. This training program offers doctoral candidates (DCs) a comprehensive training trajectory to develop a robust, affordable, and sustainable cell therapy for treating corneal blindness caused by stem cell deficiency. Key components include in-depth understanding of stem cell differentiation, developing (genetically corrected) cell products and biomaterials, and evaluating regenerative function of the cell products in corneas.
Through innovative, interdisciplinary and intersectoral research, STEM-CORE provides training of a full set of transferable and other complementary skills to DCs that enhances their career prospects across academia and industry. To achieve this, STEM-CORE has assembled a team of leading European researchers and dedicated supervisors from academic and non-academic sectors, whose expertise spans all facets of the training program.
We envision that STEM-CORE will not only establish a novel paradigm for cell therapy development but also empower aspiring researchers to tackle broad challenges in future regenerative medicine, advancing European innovation and contributing to societal progress.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Coordinator |
| Klinikum Der Universitaet Zu Koeln | Koeln | Germany | Participant |
| Universitat Des Saarlandes | Saarbrucken | Germany | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Universitat Autonoma De Barcelona | Cerdanyola Del Valles | Spain | Associatedpartner |
| Tampereen Korkeakoulusaatio Sr | Tampere | Finland | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite Paris-Saclay | Gif-Sur-Yvette | France | Associatedpartner |
| Biotalentum Tudasfejleszto Kft | Goedoello | Hungary | Participant |
| Eotvos Lorand Tudomanyegyetem | Budapest | Hungary | Associatedpartner |
| Fondazione Banca Degli Occhi Del Veneto Onlus | Zelarino Venezia | Italy | Participant |
| SBMatrices B.V. | Malden | Netherlands | Associatedpartner |
| Stichting Oogfonds Nederland | Utrecht | Netherlands | Associatedpartner |
| Universiteit Utrecht | Utrecht | Netherlands | Associatedpartner |
| Aniridia Europe | Sandefjord | Norway | Associatedpartner |
| Linkopings Universitet | Linkoping | Sweden | Participant |
| Dokuz Eylul Universitesi | Alsancak Izmir | Türkiye | Associatedpartner |
| Izmir Biyotip Ve Genom Merkezi | İzmir | Türkiye | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI